Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	297.34	139.04	143.94	87.88	149.1	251.25
Cash & Short-Term Investments	297.34	139.04	143.94	87.88	149.1	251.25
Cash Growth	88.56%	-3.41%	63.79%	-41.06%	-40.66%	-
Prepaid Expenses	0.81	1.36	1.09	2.51	3.87	3.83
Restricted Cash	0.45	0.45	0.45	-	-	-
Other Current Assets	1.35	1.28	4.39	6.03	6.63	2.79
Total Current Assets	299.95	142.13	149.87	96.42	159.6	257.88
Property, Plant & Equipment	14.27	15.87	20.41	25.91	50.61	0.29
Other Long-Term Assets	2.34	2.37	2.46	3.95	3.74	0.72
Total Assets	316.55	160.36	172.73	126.28	213.96	258.88
Accounts Payable	5.44	3.59	6.37	10.95	21.76	1.99
Accrued Expenses	14.39	9.59	9.46	14.04	25.85	4.87
Current Portion of Leases	1.67	1.88	1.65	1.52	-	-
Current Unearned Revenue	5.49	9.77	18.11	33.56	-	-
Other Current Liabilities	1.65	1.4	1.18	2.73	4.14	0.26
Total Current Liabilities	28.63	26.23	36.76	62.79	51.75	7.13
Long-Term Debt	50.85	43.94	40.51	37.97	37.19	-
Long-Term Leases	16.56	17.74	18.95	20.44	25.9	-
Other Long-Term Liabilities	1.52	0.93	1.58	4.13	3.74	0.45
Total Liabilities	97.57	88.84	97.79	125.33	118.57	7.58
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	903.58	677.86	587.94	402.39	331.03	312.43
Retained Earnings	-683.45	-602.31	-513.01	-401.44	-235.65	-61.13
Comprehensive Income & Other	-1.14	-4.03	-	-	-	-
Shareholders' Equity	218.99	71.53	74.94	0.95	95.38	251.3
Total Liabilities & Equity	316.55	160.36	172.73	126.28	213.96	258.88
Total Debt	69.08	63.56	61.11	59.93	63.09	-
Net Cash (Debt)	228.26	75.48	82.83	27.95	86.01	251.25
Net Cash Growth	141.11%	-8.88%	196.34%	-67.50%	-65.77%	-
Net Cash Per Share	0.77	0.30	0.71	0.64	2.28	14.22
Filing Date Shares Outstanding	273.92	205	187.02	63.47	38.47	37.76
Total Common Shares Outstanding	273.92	204.94	186.96	63.21	38.47	37.76
Working Capital	271.32	115.9	113.11	33.63	107.86	250.75
Book Value Per Share	0.80	0.35	0.40	0.02	2.48	6.65
Tangible Book Value	218.99	71.53	74.94	0.95	95.38	251.3
Tangible Book Value Per Share	0.80	0.35	0.40	0.02	2.48	6.65
Machinery	4.75	4.7	4.87	4.88	3.04	0.1
Construction In Progress	4.32	4.25	6.82	9.63	46	0.2
Leasehold Improvements	2.12	2.12	2.12	2.09	2.07	-

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q